Literature DB >> 20439758

Identification of protective and broadly conserved vaccine antigens from the genome of extraintestinal pathogenic Escherichia coli.

Danilo Gomes Moriel1, Isabella Bertoldi, Angela Spagnuolo, Sara Marchi, Roberto Rosini, Barbara Nesta, Ilaria Pastorello, Vanja A Mariani Corea, Giulia Torricelli, Elena Cartocci, Silvana Savino, Maria Scarselli, Ulrich Dobrindt, Jörg Hacker, Hervé Tettelin, Luke J Tallon, Steven Sullivan, Lothar H Wieler, Christa Ewers, Derek Pickard, Gordon Dougan, Maria Rita Fontana, Rino Rappuoli, Mariagrazia Pizza, Laura Serino.   

Abstract

Extraintestinal pathogenic Escherichia coli (ExPEC) are a common cause of disease in both mammals and birds. A vaccine to prevent such infections would be desirable given the increasing antibiotic resistance of these bacteria. We have determined the genome sequence of ExPEC IHE3034 (ST95) isolated from a case of neonatal meningitis and compared this to available genome sequences of other ExPEC strains and a few nonpathogenic E. coli. We found 19 genomic islands present in the genome of IHE3034, which are absent in the nonpathogenic E. coli isolates. By using subtractive reverse vaccinology we identified 230 antigens present in ExPEC but absent (or present with low similarity) in nonpathogenic strains. Nine antigens were protective in a mouse challenge model. Some of them were also present in other pathogenic non-ExPEC strains, suggesting that a broadly protective E. coli vaccine may be possible. The gene encoding the most protective antigen was detected in most of the E. coli isolates, highly conserved in sequence and found to be exported by a type II secretion system which seems to be nonfunctional in nonpathogenic strains.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20439758      PMCID: PMC2889118          DOI: 10.1073/pnas.0915077107

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  54 in total

Review 1.  Biology of type II secretion.

Authors:  M Sandkvist
Journal:  Mol Microbiol       Date:  2001-04       Impact factor: 3.501

2.  Genetic structure and distribution of four pathogenicity islands (PAI I(536) to PAI IV(536)) of uropathogenic Escherichia coli strain 536.

Authors:  Ulrich Dobrindt; Gabriele Blum-Oehler; Gabor Nagy; György Schneider; André Johann; Gerhard Gottschalk; Jörg Hacker
Journal:  Infect Immun       Date:  2002-11       Impact factor: 3.441

Review 3.  Genome-based vaccine development: a short cut for the future.

Authors:  Danilo Gomes Moriel; Maria Scarselli; Laura Serino; Marirosa Mora; Rino Rappuoli; Vega Masignani
Journal:  Hum Vaccin       Date:  2010-05-15

Review 4.  The E. coli alpha-hemolysin secretion system and its use in vaccine development.

Authors:  Ivaylo Gentschev; Guido Dietrich; Werner Goebel
Journal:  Trends Microbiol       Date:  2002-01       Impact factor: 17.079

5.  S-Fimbria-encoding determinant sfa(I) is located on pathogenicity island III(536) of uropathogenic Escherichia coli strain 536.

Authors:  U Dobrindt; G Blum-Oehler; T Hartsch; G Gottschalk; E Z Ron; R Fünfstück; J Hacker
Journal:  Infect Immun       Date:  2001-07       Impact factor: 3.441

6.  IroN functions as a siderophore receptor and is a urovirulence factor in an extraintestinal pathogenic isolate of Escherichia coli.

Authors:  Thomas A Russo; Catherine D McFadden; Ulrike B Carlino-MacDonald; Janet M Beanan; Travis J Barnard; James R Johnson
Journal:  Infect Immun       Date:  2002-12       Impact factor: 3.441

7.  Identification of vaccine candidates against serogroup B meningococcus by whole-genome sequencing.

Authors:  M Pizza; V Scarlato; V Masignani; M M Giuliani; B Aricò; M Comanducci; G T Jennings; L Baldi; E Bartolini; B Capecchi; C L Galeotti; E Luzzi; R Manetti; E Marchetti; M Mora; S Nuti; G Ratti; L Santini; S Savino; M Scarselli; E Storni; P Zuo; M Broeker; E Hundt; B Knapp; E Blair; T Mason; H Tettelin; D W Hood; A C Jeffries; N J Saunders; D M Granoff; J C Venter; E R Moxon; G Grandi; R Rappuoli
Journal:  Science       Date:  2000-03-10       Impact factor: 47.728

8.  Complete genome sequence and comparative genomic analysis of an emerging human pathogen, serotype V Streptococcus agalactiae.

Authors:  Herve Tettelin; Vega Masignani; Michael J Cieslewicz; Jonathan A Eisen; Scott Peterson; Michael R Wessels; Ian T Paulsen; Karen E Nelson; Immaculada Margarit; Timothy D Read; Lawrence C Madoff; Alex M Wolf; Maureen J Beanan; Lauren M Brinkac; Sean C Daugherty; Robert T DeBoy; A Scott Durkin; James F Kolonay; Ramana Madupu; Matthew R Lewis; Diana Radune; Nadezhda B Fedorova; David Scanlan; Hoda Khouri; Stephanie Mulligan; Heather A Carty; Robin T Cline; Susan E Van Aken; John Gill; Maria Scarselli; Marirosa Mora; Emilia T Iacobini; Cecilia Brettoni; Giuliano Galli; Massimo Mariani; Filippo Vegni; Domenico Maione; Daniela Rinaudo; Rino Rappuoli; John L Telford; Dennis L Kasper; Guido Grandi; Claire M Fraser
Journal:  Proc Natl Acad Sci U S A       Date:  2002-08-28       Impact factor: 11.205

9.  Activation of prophage eib genes for immunoglobulin-binding proteins by genes from the IbrAB genetic island of Escherichia coli ECOR-9.

Authors:  Carol H Sandt; James E Hopper; Charles W Hill
Journal:  J Bacteriol       Date:  2002-07       Impact factor: 3.490

10.  Yersinia high-pathogenicity island contributes to virulence in Escherichia coli causing extraintestinal infections.

Authors:  Sören Schubert; Bertrand Picard; Stéphanie Gouriou; Jürgen Heesemann; Erick Denamur
Journal:  Infect Immun       Date:  2002-09       Impact factor: 3.441

View more
  94 in total

Review 1.  Structure, Function, and Assembly of Adhesive Organelles by Uropathogenic Bacteria.

Authors:  Peter Chahales; David G Thanassi
Journal:  Microbiol Spectr       Date:  2015-10

2.  Antibodies against hemolysin and cytotoxic necrotizing factor type 1 (CNF1) reduce bladder inflammation in a mouse model of urinary tract infection with toxigenic uropathogenic Escherichia coli.

Authors:  Mark A Smith; Rebecca A Weingarten; Lisa M Russo; Christy L Ventura; Alison D O'Brien
Journal:  Infect Immun       Date:  2015-02-09       Impact factor: 3.441

3.  Structure-based design of a fusion glycoprotein vaccine for respiratory syncytial virus.

Authors:  Jason S McLellan; Man Chen; M Gordon Joyce; Mallika Sastry; Guillaume B E Stewart-Jones; Yongping Yang; Baoshan Zhang; Lei Chen; Sanjay Srivatsan; Anqi Zheng; Tongqing Zhou; Kevin W Graepel; Azad Kumar; Syed Moin; Jeffrey C Boyington; Gwo-Yu Chuang; Cinque Soto; Ulrich Baxa; Arjen Q Bakker; Hergen Spits; Tim Beaumont; Zizheng Zheng; Ningshao Xia; Sung-Youl Ko; John-Paul Todd; Srinivas Rao; Barney S Graham; Peter D Kwong
Journal:  Science       Date:  2013-11-01       Impact factor: 47.728

Review 4.  Expanding Role of Type II Secretion in Bacterial Pathogenesis and Beyond.

Authors:  Nicholas P Cianciotto; Richard C White
Journal:  Infect Immun       Date:  2017-04-21       Impact factor: 3.441

5.  Murine model of chemotherapy-induced extraintestinal pathogenic Escherichia coli translocation.

Authors:  Sabrina I Green; Nadim J Ajami; Li Ma; Nina M Poole; Roger E Price; Joseph F Petrosino; Anthony W Maresso
Journal:  Infect Immun       Date:  2015-06-01       Impact factor: 3.441

6.  Vaccines, reverse vaccinology, and bacterial pathogenesis.

Authors:  Isabel Delany; Rino Rappuoli; Kate L Seib
Journal:  Cold Spring Harb Perspect Med       Date:  2013-05-01       Impact factor: 6.915

7.  Diagnostic strategy for identifying avian pathogenic Escherichia coli based on four patterns of virulence genes.

Authors:  Catherine Schouler; Brigitte Schaeffer; Annie Brée; Azucena Mora; Ghizlane Dahbi; François Biet; Eric Oswald; Jacques Mainil; Jorge Blanco; Maryvonne Moulin-Schouleur
Journal:  J Clin Microbiol       Date:  2012-02-29       Impact factor: 5.948

8.  Contribution of the highly conserved EaeH surface protein to enterotoxigenic Escherichia coli pathogenesis.

Authors:  Alaullah Sheikh; Qingwei Luo; Koushik Roy; Salwa Shabaan; Pardeep Kumar; Firdausi Qadri; James M Fleckenstein
Journal:  Infect Immun       Date:  2014-06-16       Impact factor: 3.441

9.  Exploiting the power of OMICS approaches to produce E. coli O157 vaccines.

Authors:  Anjana Kalita; Mridul Kalita; Alfredo G Torres
Journal:  Gut Microbes       Date:  2014

Review 10.  Vaccine design: emerging concepts and renewed optimism.

Authors:  Sebastian K Grimm; Margaret E Ackerman
Journal:  Curr Opin Biotechnol       Date:  2013-03-07       Impact factor: 9.740

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.